Equities

Sensorion SA

Sensorion SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.714
  • Today's Change-0.018 / -2.46%
  • Shares traded10.00k
  • 1 Year change+104.00%
  • Beta1.4136
Data delayed at least 15 minutes, as of Apr 19 2024 16:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR-22.06m
  • Incorporated2009
  • Employees50.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eurofins-Cerep SA46.17m9.21m109.96m233.0011.941.839.822.381,826.411,826.419,160.0011,939.290.68141.666.04220,892.0013.6015.1916.0618.9485.5767.3019.9519.725.17112.420.000050.0014.4514.3017.0924.52----
Adocia SA5.73m-20.55m120.24m100.00------21.00-2.36-2.360.6532-1.900.1823--16.7955,048.08-65.43-25.65-341.43-37.22-----358.85-101.110.5924-2.782.81--692.73-10.0869.67---40.08--
DBV Technologies SA4.93m-95.24m121.05m88.00--0.7815--24.53-1.01-1.010.05241.610.0209--0.373871,517.02-40.35-64.67-46.22-80.94--91.59-1,929.97-1,345.10----0.0128---15.14-18.452.08---38.41--
Transgene SA7.63m-22.33m146.84m158.00--9.38--19.24-0.2227-0.22270.07590.15530.1368--4.2848,316.46-40.00-24.81-50.27-29.79-----292.48-193.24----0.4764---23.681.5131.94--14.44--
Eurobio Scientific SA128.01m7.91m152.09m304.0019.650.96056.241.190.75520.755211.9115.450.48563.754.48948,222.303.0021.703.5328.7945.2850.596.1825.062.704.110.37990.00-17.3829.03-58.81---6.24--
Genfit SA38.18m-28.89m158.72m159.00--2.34--4.16-0.5814-0.58140.76811.360.1961542.003.52240,100.60-14.84-12.57-18.55-15.3094.3294.96-75.69-76.232.94-7.780.5080--43.7038.49-21.82---3.27--
Inventiva SA17.48m-110.43m165.83m112.00------9.49-2.45-2.450.3854-0.61460.1884--9.18156,044.60-116.84-54.30-207.08-69.98-----620.31-669.970.9524-19.986.96--43.5040.46-103.46---0.33--
Cellectis SA22.94m-55.71m170.14m----1.84--7.42-1.06-1.560.4451.290.0998--40.86---27.15-21.38-34.66-26.37---61.60-272.10-268.89---4.960.5559---33.35-5.27-5.77---14.21--
Aelis Farma SA5.55m-5.57m172.35m22.00--10.02--31.04-0.4123-0.41230.41871.300.1405--1.36252,409.10-14.09-30.28-22.24-49.56-----100.29-168.222.41--0.1337---58.03---2,589.20------
Innate Pharma SA51.90m-7.57m173.85m179.00--3.35--3.35-0.0939-0.09390.64510.6420.2648--5.67289,949.70-3.86-8.83-4.87-12.1194.5093.17-14.59-55.55----0.6408--4.68-8.2786.94--10.50--
Sensorion SA0.00-22.06m219.78m50.00--4.12-----0.2063-0.20630.000.17790.00-------51.64-35.12-71.66-46.97------------0.0794------4.94--126.45--
Nanobiotix SA0.00-58.78m244.86m101.00---------1.68-1.680.00-1.530.00----0.00-97.14-55.16-411.11-75.16-------89,710.66---6.62-----100.00---21.36---42.16--
Euroapi SA1.02bn-189.70m246.00m3.67k--0.2646--0.2414-2.01-2.0110.739.780.60861.384.24277,705.10-11.34---15.93--16.15---18.63--0.6573--0.1955--3.87---1,164.67------
Carbios SA-100.00bn-100.00bn313.33m104.00--1.34----------13.92-----------9.92---10.77-------3,365.229.43--0.1719---65.71-53.321.86------
Medincell SA10.85m-26.42m316.87m138.00------29.21-1.02-1.020.4086-0.89650.2605--6.8175,853.15-63.46-59.54-115.15-117.3660.4368.38-243.58-451.26---4.291.69--141.788.96-29.04---2.87--
Data as of Apr 19 2024. Currency figures normalised to Sensorion SA's reporting currency: Euro EUR

Institutional shareholders

11.66%Per cent of shares held by top holders
HolderShares% Held
Invus Public Equities Advisors LLCas of 31 Dec 202226.49m9.61%
Fidelity Management & Research Co. LLCas of 29 Feb 20245.64m2.05%
Gestys SAas of 26 Jan 202428.00k0.01%
Data from 31 Dec 2023 - 23 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.